Eastman Chemical is a global specialty chemicals company that was incorporated in 1920 and spun out from Eastman-Kodak in 1994. It is headquartered in Kingsport, Tennessee, and reports four segments: additives and functional products, or AFP; advanced materials, or AM; chemical intermediates, or CI; and fibers. The company generates most of its sales outside of the US, with a strong presence in Asian and European markets.
Last trade$62.48
Day change-$1.015 (-1.60%)
Day range$62.31 – $63.80
Volume587,270
Market cap$7.26B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$7.26B
Price / earnings
11.22×
Price / book
1.16×
Price / sales
0.8×
EV / sales
1.29×
EV / EBITDA
7.87×
Profitability
Earnings per share
$5.66
Return on assets
4.18%
Return on equity
10.31%
Dividend yield
5.26%
Liquidity and leverage
Debt / equity
0.83×
Current ratio
1.57×
Quick ratio
0.79×
Cash ratio
0.28×
Cash flow
Price / cash flow
8.26×
Price / free cash flow
15.48×
Free cash flow
$469M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for EMN, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$2.39B
$2.51B
$2.18B
$1.97B
$2.2B
$2.29B
$2.29B
$2.25B
Cost of revenue
$1.85B
$1.95B
$1.75B
$1.64B
$1.77B
$1.78B
$1.72B
$1.69B
Gross profit
$532M
$560M
$431M
$338M
$433M
$506M
$567M
$554M
Selling, general and administrative
$171M
$185M
$178M
$159M
$160M
$157M
$182M
$182M
Research and development
$63M
$65M
$60M
$58M
$63M
$67M
$67M
$66M
Total operating expenses
$234M
$251M
$230M
$250M
$243M
$237M
$257M
$200M
Operating income
$298M
$309M
$201M
$88M
$190M
$269M
$310M
$354M
Interest expense
-$56M
-$55M
$0
-$52M
-$54M
-$53M
$0
-$52M
Income before taxes
$249M
$256M
$136M
$12M
$134M
$169M
$253M
$297M
Income taxes
-$4M
$72M
$29M
-$93M
$65M
$29M
$70M
-$34M
Net income
$253M
$184M
$107M
$105M
$69M
$140M
$183M
$331M
Net income attributable to common shareholders
$252M
$183M
$107M
$105M
$69M
$140M
$182M
$330M
EBITDA
$432M
$442M
$341M
$273M
$339M
$409M
$445M
$493M
Basic earnings per share
$2.21
$1.60
$0.93
$0.92
$0.60
$1.22
$1.58
$2.85
Diluted earnings per share
$2.19
$1.59
$0.93
$0.92
$0.60
$1.20
$1.57
$2.82
Recent news
Company coverage with links to the original publishers.
Eastman Chemical reported Q3 2026 adjusted EPS of $1.84, up 61.4% YoY but missing estimates by 4.2%. Sales rose 8.3% to $2,385M, driven by 7% price increases and improved asset utilization, though elevated input costs remained a headwind. The company projects 2026 adjusted EPS of $6-$6.20 and operating cash flow of ~$850M, supported by cost-reduction initiatives and favorable price-cost dynamics.
Eastman Chemical reported Q3 2026 earnings of $1.84 per share, missing the consensus estimate of $1.92, though revenues slightly beat expectations at $2.39 billion. The company received a Zacks Rank #5 (Strong Sell) rating due to unfavorable estimate revisions, and the Chemical - Diversified industry ranks in the bottom 16% of all industries. Northern Technologies, also in the same sector, is expected to report upcoming results with 200% year-over-year earnings growth.
Eastman Chemical reported Q3 2026 revenue of $2.39 billion, up 8.3% year-over-year, matching consensus estimates. However, EPS of $1.84 missed expectations of $1.92 by 4.17%. The company showed mixed segment performance, with Additives & Functional Products exceeding estimates while Advanced Materials and Fibers underperformed. The stock carries a Zacks Rank #5 (Strong Sell) rating.
LyondellBasell is expected to report Q3 2026 earnings of $2.73 per share (up 170.3% YoY) with revenues of $8.47 billion (up 9.7% YoY) on October 30. However, the company has a negative Earnings ESP of -1.18%, suggesting analysts have recently become bearish on earnings prospects. With a Zacks Rank #3 (Hold), the stock is not considered a compelling earnings-beat candidate.
DuPont delivered 4% organic sales growth in Q2 2026 driven by high-growth markets including healthcare, water, aerospace, and EVs. The company raised its full-year 2026 EBITDA and earnings guidance following acquisitions of Spectrum Plastics and Donatelle Plastics, and is targeting 3% productivity gains. Peer chemical companies Dow, Air Products, and Eastman Chemical also raised their 2026 guidance.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Sep 15, 2026
$0.84
Oct 7, 2026
recurring
Jun 15, 2026
$0.84
Jul 8, 2026
recurring
Mar 13, 2026
$0.84
Apr 8, 2026
recurring
Dec 15, 2025
$0.84
Jan 8, 2026
recurring
Sep 15, 2025
$0.83
Oct 7, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.